References

  1. Galloway J. Remarks on Hodgkin's disease. Br Med J. 1922 Dec 23; 2(3234): 1201-1204. PubMed | Google Scholar

  2. Lee JC, Yamauchi H, Hopper Jr J. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966 Jan;64(1):41-51. PubMed | Google Scholar

  3. Eagen JW. Glomerulopathies of neoplasia. Kidney Int. 1977 May;11(5):297-303. PubMed | Google Scholar

  4. Dabbs DJ, Striker LM, Mignon F, Striker G. Glomerular lesions in lymphomas and leukemias. Am J Med. 1986; 80(1):63-70. PubMed | Google Scholar

  5. Meyrier A, Delahousse M, Callard P, Rainfray M. Minimal change nephrotic syndrome revealing solid tumors. Nephron. 1992; 61(2):220-223. PubMed | Google Scholar

  6. Jeroudi A, Kadikoy H, Gaber L, Ramanathan V, Frome A, Anwar N, Abdellatif A. Profound nephrotic syndrome in a patient with ovarian teratoma. Saudi J Kidney Dis Transpl. 2013 Jul;24(4):777-82. PubMed | Google Scholar

  7. Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant. 2003;18(Suppl 6):vi52-58. PubMed | Google Scholar

  8. Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009 Apr;70(1):39-58. PubMed | Google Scholar

  9. Hoyt RE, Hamilton JF. Ovarian cancer associated with the nephritic syndrome. Obstet Gynecol. 1987 Sep;70(3 Pt 2):513-4. PubMed | Google Scholar

  10. Torres VE, Donadio JV Jr. Cical aspects of the nephrotic syndrome in systemic diseases; in Cameron SI, Glassock RJ (eds): Nephrotic syndrome, ed 1. New York, Dekker. 1988; pp555-651.

  11. Beauvais P, Vaudour G, Boccon Gibod L, Levy M. Membranous nephropathy associated with ovarian tumour in a young girl: recovery after removal. Eur J Pediatr. 1989; 148(7):624-625. PubMed | Google Scholar

  12. Fernandez-Miranda C, Mateo S, Gonzalez-Gomez C, Ballestin C. Systemic amyloidosis and ovarian carcinoma. Postgrad Med J. 1994 Jul; 70(825): 505-506. PubMed | Google Scholar

  13. Salazar-Exaire D, Rodriguez A, Galindo-Rujana ME, Briones JC, Arenas-Osuna J, Rocha LM et al. Membranoproliferative glomerulonephritis associated with a mixed-cell germinal ovary tumor. Am J Nephrol. 2001 Jan-Feb;21(1):51-54. PubMed | Google Scholar

  14. Forgy AP, Ewing TL, Flaningam J. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration. Gynecol Oncol. 2001 Jan;80(1):96-8. PubMed | Google Scholar

  15. Topalak O, Saygili U, Soyturk M, Karaca N, Batur Y, Uslu T, Erten O. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol. 2002 Apr;85(1):108-13. PubMed | Google Scholar

  16. Kim YT, Rha SY, Shim CY, Sohn JH, Kim C, Yu NC et al. A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma. Yonsei Med J. 2003 Jun 30;44(3):539-43. PubMed | Google Scholar

  17. Ryu DR, Yoo TH, Kim YT, Jeong HJ, Cho NH, Kang SW. Minimal change disease in a patient with ovarian papillary serous carcinoma. Gynecol Oncol. 2004 May;93(2):554-6. PubMed | Google Scholar

  18. Ata A, Gürses I, Klyklm A, Arlcan A. Nephrotic syndrome associated with gemcitabine use in a patient with ovarian cancer. Am J Case Rep. 2012;13:268-270. PubMed | Google Scholar

  19. Kilis-Pstrusinska K, Szajerka U, Zwolinska D. Unspecific increase of tumor markers in a girl with nephrotic syndrome andovarian teratoma. Ren Fail. 2013;35(5):654-656. PubMed | Google Scholar

  20. Schnaper HW, Robson AM. Nephrotic syndrome: minimal change nephrotic syndrome, focal glomerulosclerosis, and related disease, In: Schrier RW, Gottschalk CW, editors: disease of the kidney. Fifth ed Boston: little Brown and Co. 1993; 1731-1784.

  21. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 1991 Sep;40(3):453-60. Google Scholar